Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F9BL0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,864
Award facts
- Contract value 100% obligated
- $20,863.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $20,863.51 to supply Dupixent 300 mg/2 ml pen injectors on November 13, 2025, with completion expected by November 14, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's pharmaceutical supply operations to federal military and veteran healthcare systems.
Dupixent is a specialty pharmaceutical used to treat atopic dermatitis, asthma, and other inflammatory conditions, representing the type of brand-name specialty medication that AmerisourceBergen regularly supplies through its DLA contract portfolio. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages its primary IDC to fulfill ongoing delivery orders across diverse therapeutic domains in support of military healthcare programs worldwide. The DLA Troop Support Medical contract demonstrates the company's established capability to meet federal procurement requirements for specialized pharmaceuticals and medical supplies on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F9BL0?
SPE2DR26F9BL0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BL0 worth?
The government has obligated $20,864 on SPE2DR26F9BL0.
Is contract SPE2DR26F9BL0 an order under another contract?
Yes. SPE2DR26F9BL0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BL0 competed?
The extent of competition for SPE2DR26F9BL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award